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1. Introduction 
Moore [l] and Vasington et al. [2] have demon- 
strated a specific inhibition of mitochondrial reactions 
associated with active Ca’ + transport by commercial 
preparations of Ruthenium Red. However, such prepa- 
rations generally contain less than 20% of the pure 
compound [3]. Recent studies in this laboratory [4, 
51, which concentrated on the mechanism of inhibi- 
tion of the Ca*+ carrier by pure Ruthenium Red 
([(NH& Ru-0-Ru(NH&,-0-Ru (NH&] 6+Cl& 
4H2 0; [6] ), suggested that a colourless contaminant 
of the crude preparations has inhibitory properties 
similar to those of Ruthenium Red itself. 
Identification of the compound would be of some 
interest as it should provide further information on 
the nature of the sites involved in non-competitive 
inhibition of the Ca*+ carrier. A second feature, 
inherent in its lack of absorption in the visible spectrum, 
is that it would not interfere with optical measurements 
of mitochondrial redox components and thus would 
be more useful than Ruthenium Red in determining 
the relation between non-competitive carrier inhibition 
and energy transduction. 
This report describes preliminary attempts to isolate 
and identify this compound. 
2. Materials and methods 
Mitochondria were isolated from rat liver and 
assayed for protein as described previously [7]. 
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Mitochondrial volume changes were monitored semi- 
quantitatively by measuring Es20 in a Varian-Techtron 
split-beam recording spectrophotometer; the same 
instrument was used to record absorbance spectra of 
the ruthenium complexes. Oxygen uptake was measured 
polarographically [8]. 
Scintillation counting was carried out as described 
previously [ 51 . 
Thin-layer chromatography media were products 
of the Gelman Instrument Corp. (Michigan, USA); 
silicic acid (for column chromatography) was from E. 
Merck A.-G. (Darmstadt, Germany). 
’ O3 Ru was purchased from the Radiochemical 
Centre (Amersham, U.K.) and RuCl3, 3H2 0 from 
Hopkin and Williams (Essex, UK); [Ru(NH,), Cl ] Cl 2 
and [Ru(NH3)6] Cl3 were kindly provided by Dr. J. 
Broomhead (Chemistry Dept., Australian National 
University). 
3. Results and discussion 
The first approach adopted was to synthesize 
Ruthenium Red from Ru3+ with the inclusion of 
lo3 Ru3+ to enable detection of all ruthenium complexes. 
Since commercial Ruthenium Red is probably syn- 
thesized under similar conditions, the inhibitory 
impurities of commercial preparations should be 
present and labelled in the resulting mixture of products. 
Two g of RuC13, 3H2 0 and 34 &i ’ O3 Ru 
were used as the starting materials in the synthetic 
procedure described by Fletcher et al. [6]. The super- 
natants from successive Ruthenium Red crystalliza- 
tions were combined, and this solution was used as the 
source of material in subsequent analyses. 
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Fig. 1. Absorbance spectra of fractions resolved by thin-layer chromatography. A sample of the crude mixture (see text) was 
chromatographed on Gelman ITLC (Type SG) with 75% methanol, 25% ammonium acetate (0.1 M final concentration). The nine 
visible bands were cut into thin strips and eluted in small volumes of 0.1 M ammonium acetate (pH 5.0). Spectra of centrifuged 
eluates were recorded against a solvent blank. 
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Partial separation of the components of this mixture 
was achieved by using sheets of cellulose, DEAE- 
cellulose and various thin-layer silica and alumina gel 
media as the supporting adsorbant phase, with combi- 
nations of methanol and ammonium acetate [3] as 
the solvent. The best resolution of visible components 
was attained on cellulose impregnated with silica gel 
(Gelman ITLC: Type SG) with a solvent of 95% 
methanol: 25% ammonium acetate (0.1 M final con- 
centration). The nine visible bands from such a 
chromatogram were eluted immediately with 0.1 M 
ammonium acetate (pH 5) and the eluates were centri- 
fuged to remove suspended material. Each of these 
nine fractions was then analysed for visible- and ultra- 
violet-absorbing material, for radioactivity, and for its 
ability to inhibit mitochondrial Ca*+ transport. 
Fig. 1 shows the absorbance spectra of the nine 
fractions. Six distinct peaks are apparent, three in the 
visible region and three in the ultraviolet. The peak at 
536 nm and the shoulder at 477 nm are due to 
Ruthenium Red and Ruthenium Brown respectively 
[3] ; the peak at 355 nm is partially attributable to 
these complexes [3,6] but is due also to an additional 
component since its height is not related to the height 
of the visible peaks for Ruthenium Red and Brown. 
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Fig. 2. Radioactivity and inhibitory activity of fractions re 
solved by thin-layer chromatography. Samples of the nine 
fractions (fig. 1) were counted for radioacitivity (o) and for 
their ability to inhibit the initial rate of respiration-support- 
ed Cal+ transport (0). The latter effect was assessed by 
measuring the initial rate of mitochondrial swelling (Es z o ) 
when 333 FM Ca’+ was added to 3 ml of medium containing 
4.2 mg of mitochondrial protein in 250 mM sucrose, 5 mM 
HEPES-Tris (pH 7.4), 5 mM succinate-Tris, 1 PM rotenone, 
and 10 mM acetate-Tris. 
The radioactivity due to lo3 Ru, and hence the 
proportion of total ruthenium, is greatest in fractions 
seven and eight (fig. 2); so too is the potency of inhibi- 
tion of Ca*+transport (fig. 2). Since Ruthenium Red is 
most concentrated in fraction six (fig. 1) the inhibitory 
activity of the latter fractions is due to some other 
component. 
The properties of the ruthenium complexes revealed 
by the thin-layer separation and elution procedures, 
together with a series of qualitative adsorption tests, 
suggested that chromatography on a column of silica 
under mild acid conditions would be more successful 
in resolving the components of the mixture. The column 
adsorbent was prepared by extensive washing and 
filtration of 70-325 mesh silicic acid in 0.1 M 
ammonium acetate (pH 5.0) which was used to pack a 
1.5 X 50 cm column. The sample was prepared by 
adsorbing the crude mixture of lo3Ru complexes to 
a small amount of silicic acid at pH 8.5 in 0.1 M 
ammonium acetate which was carefully layered on top 
of the column. This was eluted with 0.1 M ammonium 
acetate (pH 5.0) under nitrogen pressure and 10 ml 
fractions were collected until the first coloured band 
reached the bottom of the column (at least six 
coloured components were visible). 
Fig. 3 shows the distribution of radioactivity (’ O3 Ru) 
in the eluate and the activity of each fraction in 
causing inhibition of Ca* ‘-stimulated respiration. Two 
peaks of inhibitory activity were obtained: the first 
corresponded to the initial peak of radioactivity, but 
this was less potent than the material concentrated in 
the second peak (fig. 3). This second region of inhibi- 
tory material was associated with only a small shoulder 
in the radioactivity profile (fig. 3). 
Ultraviolet spectra of the column fractions (fig. 4) 
revealed the presence of four separate absorbing 
species, none of which had been completely resolved. 
There is no obvious correlation between any one of 
these species and the inhibition profile with the possible 
exception of the small peak at 355 nm (fig. 4); the 
material absorbing at 255 nm may also show a 
reasonable correlation. 
The second approach was to test ruthenium ammine 
complexes for inhibitory activity. The rationale 
behind this search was provided by three separate 
lines of evidence: firstly, since the unknown compound 
probably inhibits at the same site as does Ruthenium 
Red, it would be expected to be structurally related. 
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Fig. 3. Radioactivity and inhibitory activity of fractions resolv- 
ed by silicic acid chromatography. A sample of the crude 
mixture was chromatographed on a silicic acid column as 
&scribed in the text. The fraction volume was 10 ml and the 
flow rate was 85 ml/hr. Room temperature: (a) Radioactivity 
in 300 ~1 aliquots; (b) per cent inhibition of the initial rate of 
respiration-supported Ca2* transport caused by 30 ~1 (o) or 
5 ~1 (0) samples of each fraction. The initial rate of Cal+ 
transport was measured as the respiratory stimulation induced 
by the addition of 500 PM Ca*+ to 5.6 (o) or 2.8 (0) mg of 
mitochondrial protein in 2 ml of 250 mM sucrose, 5 mM 
HEPES-Tris (pH 7.4), 5 mM succinate-Tris and 10 mM 
acetate-Tris at 30°C. 
The mononuclear analogues are [Ru(NH,)e] 3+, [Ru 
(NWsW2+, and [Ru(NH~&,(OH)~] +. Secondly, 
Tashmukhamedov et al. [9] have reported that 
‘hexamine cobaltichloride’ ([Co(NH,),] 3 3 inhibits 
mitochondrial Ca* + transport. The ammine complexes 
of trivalent cobalt are similar in many respects to those 
of Ru*I* (e.g. ref. [ 1 O]), suggesting that inhibition 
by WNH,), 1 3+ and the unknown ruthenium com- 
plex may be due to structurally-similar compounds. 
Finally, the ammoniacal reaction mixture from which 
Ruthenium Red is synthesized contains a large pro- 
portion of ruthenium ammine complexes (J. Broom- 
head, personal communication). 
[Ru(NH,), ] 3+ was tested by dissolving [Ru(NH,), 
Cl3 in water (h,, = 275 nm [ 1 l] ) and using the 
solution immediately. It caused no inhibition of Ca*‘- 
stimulated respiration at concentrations up to 0.5 mM. 
Neither did [Ru(NH3)s0H] *+(XmX = 295 nm), 
which was prepared as a fresh solution of [Ru(NH3)s 
Cl] Cl2 in 0.1 M NH3 (the chloro-complex (hmax = 
327 nm) undergoes very rapid base-catalysed hydrolys- 
is [lo]). However, when a 10 mM solution of ruthen- 
ium pentammine chloride in 0.1 M NH, was allowed 
to stand overnight at room temperature it developed 
inhibitory activity. The resulting solution was dark 
brown, and in addition to the hydroxypentammine 
absorption at 295 nm its ultraviolet spectrum show- 
ed a shoulder at 355 nm. The ratio of the absorbance 
at 355 nm to the inhibitory activity of the solution 
was different from the similar relations for 4he active 
fractions from the chromatography procedures de- 
scribed above. 
A sample of the aged solution was applied to a 
microcolumn of silicic acid and eluted with 0.1 M 
ammonium acetate (pH 5). The only spectral com- 
ponent in the inhibitory fractions of eluate was a strong 
symmetrical peak at 295 nm due to [Ru(NH3)sOH] *‘. 
The shoulder at 355 nm in the original spectrum had 
disappeared and was apparently due to Ruthenium 
Red and/or a brown complex, both of which adsorb- 
ed more strongly to the column than did the major 
inhibitory compound. There was no evidence of com- 
ponents absorbing at 255 nm. 
This work, although incomplete, conclusively 
demonstrates the existence of a colourless ruthenium 
complex inhibitory to Ca*+ transport, but provides 
little positive evidence of its identity. That its molec- 
ular weight is considerably lower than 800 and that 
it is a major contaminant of commercial Ruthenium 
Red were established in earlier studies [5] . Its weak 
adsorption to silica at pH 5.0 implies a lower cation- 
ic charge than Ruthenium Red. It may absorb in the 
ultraviolet, but if so it has a low extinction coefficient; 
there is insufficient information available in the 
literature to assign all spectral peaks to specific com- 
plexes, or to establish the products arising from treat- 
ment of [Ru(NH3)OH] *+ with ammonia. 
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Fig 4. Ultraviolet absorbance spectra of fractions resolved by silicic acid chromatography. The spectra of the inhibitory fractions 
shown in fig. 3 were recorded at room temperature against a solvent blank. 
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